Farina Claudio, Manso Esther, Sanna Silvana, Lombardi Gianluigi, Faggi Elisabetta, Fazii Paolo, Andreoni Stefano
UO Microbiologia, AO Ospedale San Carlo Borromeo, 20153 Milano, Italia.
Diagn Microbiol Infect Dis. 2007 Feb;57(2):225-7. doi: 10.1016/j.diagmicrobio.2006.06.017. Epub 2006 Aug 28.
The purpose of this study was to verify the standard procedures and minimum level of knowledge of Italian public laboratories involved in the management of antifungal susceptibility testing (AST). Two nationwide surveys were performed in 1999 and 2004. One hundred and two Italian hospitals located in 85 provincial capitals (82.5%) participated to these surveys. In 1999, 28 (27.5%) laboratories versus 16 (15.7%) in 2004 stated that they did not perform any susceptibility testing. Some discrepancies observed in the survey confirm that AST is difficult to be correctly managed, and that it can be performed only in very well-trained centers. The great variability of the results of MIC determination and clinical interpretation underlines the urgent need to improve knowledge about indications, method choice, and interpretative criteria for AST both for clinical microbiologists and clinicians.
本研究的目的是验证参与抗真菌药敏试验(AST)管理的意大利公共实验室的标准程序和最低知识水平。1999年和2004年进行了两项全国性调查。位于85个省会城市(82.5%)的102家意大利医院参与了这些调查。1999年,28家(27.5%)实验室表示未进行任何药敏试验,而2004年这一比例为16家(15.7%)。调查中观察到的一些差异证实,AST难以正确管理,并且只能在训练有素的中心进行。MIC测定结果和临床解释的巨大变异性突出表明,临床微生物学家和临床医生迫切需要提高有关AST的适应证、方法选择和解释标准的知识。